Pediatric parkinsonism: clinical review and a proposed clinical algorithm - Report - MDSpire

Pediatric parkinsonism: clinical review and a proposed clinical algorithm

  • By

  • Valentina Naranjo-Lobo

  • María José Hidalgo-Bravo

  • Daniela Munoz-Chesta

  • Mónica Troncoso-Schifferli

  • July 7, 2026

  • 0 min

Share

Clinical Report: Childhood Parkinsonism: A Comprehensive Review

Overview

Pediatric parkinsonism (PP) is a rare movement disorder characterized by bradykinesia and rigidity, with tremor being less frequent. Additional features include gait disturbances and impaired postural reflexes. In younger children, hypotonia is often a predominant sign. Clinical expression evolves with neurodevelopment and is frequently associated with other movement abnormalities, such as dystonia. The condition may arise from a variety of pathophysiological mechanisms and multiple etiologies, with genetic causes being particularly prominent. A classification system has been proposed based on age of onset, clinical features, prognosis and etiology, comprising: Developmental parkinsonism, Infantile degenerative parkinsonism, Parkinsonism in the setting of postnatal neurodevelopmental disorders, Parkinsonism associated with multisystemic brain diseases, Juvenile parkinsonism and dystonia-parkinsonism and Acquired parkinsonism. A specific assessment tool—the Infantile Parkinsonism-Dystonia Rating Scale—has recently been developed and primarily validated to quantify severity, monitor disease progression and assess treatment response.

Background

Pediatric parkinsonism is a rare but disabling condition that can significantly impact a child's development and quality of life. Understanding its diverse etiologies, particularly the genetic factors involved, is crucial for timely diagnosis and intervention.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Pediatric parkinsonism is characterized by bradykinesia, rigidity, and hypotonia, with additional features evolving with age.
  • It can be classified into several categories based on age of onset and clinical features.
  • Genetic causes are predominant, with over 70 genes implicated in the condition.
  • A specific assessment tool, the Infantile Parkinsonism-Dystonia Rating Scale, has been developed to quantify severity and monitor disease progression.

Clinical Implications

Healthcare professionals should be aware of the clinical complexities of pediatric parkinsonism to facilitate early diagnosis.

Conclusion

Pediatric parkinsonism is an underrecognized condition that requires heightened awareness among clinicians. A comprehensive understanding of its clinical presentation and etiology is essential.

Related Resources & Content

  1. Frontiers in Neurology, 2026 -- Pediatric Parkinsonism: Clinical Review and a Proposed Clinical Algorithm
  2. Frontiers in Neurology — Bipolar disorder and subsequent Parkinson's disease: a meta-analysis of cohort studies
  3. Brain — Longitudinal Alterations in Cerebral Compensation Influence the Progression of Parkinson's Disease
  4. Frontiers in Neurology — Highlighting the value of polymyography in childhood onset movement disorders
  5. phoenix children's medical connection — Treatable Pediatric Neuromuscular Disorders
  6. Treatable Pediatric Neuromuscular Disorders
  7. Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency
  8. Frontiers | PEDIATRIC PARKINSONISM: CLINICAL REVIEW AND A PROPOSED CLINICAL ALGORITHM
  9. KEBILIDI | FDA

Original Source(s)

Related Content